Dr. Iyabo Tinubu-Karch
NeOnc Technologies Appoints Sidra Medicine CEO and Forbes Top 100 Healthcare Leader, Dr. Iyabo Tinubu-Karch, to Scientific Advisory Board
April 18, 2023 09:15 ET | NeOnc Technologies Holdings, Inc.
LOS ANGELES, April 18, 2023 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc., a clinical stage medical biotechnology company, has appointed Dr. Iyabo Tinubu-Karch to its scientific advisory...
logo 600X600.png
Pediatric Vaccines Market to Surpass US$ 69,482.2 Million by 2030, Says Coherent Market Insights (CMI)
April 04, 2023 09:15 ET | CMI
Burlingame, April 04, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global pediatric vaccines market is estimated to be valued at US$ 46,424.3 million in 2023 and is expected to...
ab2bio logo.png
AB2 Bio Completes Enrolment in Pivotal Phase 3 Trial of Tadekinig alfa to Treat Primary Monogenic IL-18 Driven HLH
March 07, 2023 03:00 ET | AB2 Bio Ltd
Topline pivotal Phase 3 results expected during second half of 2023Potential new treatment option in ultra-rare, life-threatening, primarily pediatric disease with no approved therapies Lausanne...
neonc-logo-vector.png
NeOnc Technologies Engages Anova Enterprises to Pursue Pediatric Brain Tumor Indication and FDA Fast-Track Status for NEO100®
March 06, 2023 08:00 ET | NeOnc Technologies Holdings, Inc.
Anova Enterprises, a clinical research organization, to prepare FDA Fast Track and Rare Pediatric Designation application for NEO100® for Pediatric High-Grade Gliomas (pHGGS) brain tumors.AnovaOS™...
CHC_PCC_logos-01.png
Canadians Agree: It’s Time for All Levels of Government to Prioritize Children’s Health
February 06, 2023 17:32 ET | Children’s Healthcare Canada
OTTAWA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Nearly all Canadians agree that it is time for decision-makers to put children first in health care planning and spending. New public opinion research,...
NeuroSigma.png
NeuroSigma Announces Strategic Digital Marketing Partnership with Data360
January 31, 2023 09:00 ET | NeuroSigma, Inc.
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology for treating...
2019-WishBoneLogo_Reg-CMYK-01.png
WishBone Medical Partners With Clubfoot Solutions to Distribute the Iowa Brace for Pediatric Patients in the U.S.
January 05, 2023 08:00 ET | WishBone Medical, Inc.
WARSAW, Ind., Jan. 05, 2023 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. has entered into a distribution agreement with Clubfoot Solutions, naming WishBone the exclusive pediatric medical device...
Subject Matter Experts Podcast Hosted by Qamar Zaman
San Antonio TX Dentist Dr. Carlen Blume of Blume Pediatric Dentistry Interviewed by Qamar Zaman
December 19, 2022 21:28 ET | The Subject Matter Expert Podcast by Qamar Zaman
San Antonio, TX, Dec. 19, 2022 (GLOBE NEWSWIRE) --  In 2010, Dr. Carlen Blume established her pediatric dentistry practice and has become one of the go-to full-service pediatric care providers...
GMILogo_Vertical-Gradient.png
Extracorporeal Membrane Oxygenation Market to hit USD 639 Million by 2032, says Global Market Insights Inc.
December 12, 2022 06:10 ET | Global Market Insights Inc.
Selbyville, Delaware, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The extracorporeal membrane oxygenation market value is set to reach USD 639 million by 2032, according to a new research report by Global...
logo.PNG
Ark Biopharmaceutical Announces NMPA Acceptance and Priority Review of New Drug Application for Ziresovir for Treatment of RSV Infection
December 08, 2022 20:00 ET | Shanghai Ark Biopharmaceutical Co., Ltd.
SHANGHAI, China, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Shanghai Ark Biopharmaceutical Co., Ltd. (Ark Biopharmaceutical), a biopharma company dedicated to the discovery and development of drugs for...